Corporate Counsel: Pharma and Biotech Getting in the Post-grant IP Game

Seventy-Eight Percent of Chief IP Counsel for Pharmaceutical & Biotechnology Companies Say America Invents Act Has Changed the Patent Process, Consero Survey Reveals
January 26, 2015
Entrepreneur: Creating The Right Culture For Startup Success
January 27, 2015

Corporate Counsel: Pharma and Biotech Getting in the Post-grant IP Game

Originally Published in Corporate Counsel | January 26, 2015 | By Lisa Shuchman

biotechnology helix

By now it’s well-known that the post-grant proceedings implemented with the America Invents Act have have had a huge impact on the patent practices of companies in the technology and electronics fields. But the proceedings also have significantly altered the patent strategies used by in-house lawyers in the pharmaceutical and biotechnology sectors, according to a new survey.

See full article here.